Registrational Phase III trial in Type 1 Diabetes with Diamyd expands to the US (Información remitida por la empresa firmante) The first clinical site in the United States is pending imminent initiation in the precision medicine Phase III trial DIAGNODE-3, which is ongoing in eight European countries.
Crayfish BidCo Oy supplements the tender offer document dated 7 March 2023 regarding its voluntary public cash tender of
Crayfish BidCo Oy supplements the tender offer document dated 7 March 2023 regarding its voluntary public cash tender of
CRAYFISH BIDCO OY SUPPLEMENTS THE TENDER OFFER DOCUMENT DATED 7 MARCH 2023 REGARDING ITS VOLUNTARY PUBLIC CASH TENDER OF
CRAYFISH BIDCO OY SUPPLEMENTS THE TENDER OFFER DOCUMENT DATED 7 MARCH 2023 REGARDING ITS VOLUNTARY PUBLIC CASH TENDER OF
